RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Acute Lung Injury
Accession: DOID:9004610
browse the term
Definition: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
Synonyms: exact_synonym: Acute Lung Injuries
primary_id: MESH:D055371 ; RDO:0007706
xref: EFO:0004610
G
ACE
angiotensin I converting enzyme
treatment
ISO
associated wit Escherichia coli Infections
RGD
PMID:29990483
RGD:40400897
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
ACE2
angiotensin converting enzyme 2
treatment severity
ISO
human protein in a mouse model CTD Direct Evidence: therapeutic associated with avian influenza;protein:decreased expression:lung (mouse) associated with Escherichia coli Infections
RGD CTD
PMID:16001071 PMID:25391767 PMID:27302421 PMID:29990483
RGD:32716389 RGD:40400897 RGD:40818412
NCBI chr X:8,189,267...8,229,415
Ensembl chr X:15,470,896...15,510,891
G
ACVR1
activin A receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297076
NCBI chr2B:44,994,175...45,133,490
Ensembl chr2B:162,234,823...162,297,805
G
ADAR
adenosine deaminase RNA specific
treatment
ISO
RGD
PMID:18520702
RGD:10755331
NCBI chr 1:129,937,993...129,983,747
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
associated with Sepsis
RGD
PMID:22156343 PMID:23522481
RGD:5686380 RGD:8695940
NCBI chr 3:183,876,051...183,889,723
Ensembl chr 3:192,341,320...192,354,885
G
ADRA2A
adrenoceptor alpha 2A
ISO
RGD
PMID:21542970
RGD:6480481
NCBI chr10:107,669,860...107,673,685
G
AFF4
ALF transcription elongation factor 4
treatment
ISO
RGD
PMID:31466050
RGD:155631268
NCBI chr 5:128,292,700...128,374,511
Ensembl chr 5:134,457,398...134,532,625
G
AGER
advanced glycosylation end-product specific receptor
ISO
associated with Hyperoxia; protein:decreased expression:bronchoalveolar lavage fluid (rat)
RGD
PMID:23576805
RGD:7244254
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
AKAP12
A-kinase anchoring protein 12
ISO
mRNA,protein:increased expression:lung
RGD
PMID:23912647
RGD:14348970
NCBI chr 6:149,058,350...149,176,710
Ensembl chr 6:153,757,081...153,873,925
G
AKT1
AKT serine/threonine kinase 1
severity
ISO
RGD
PMID:23904165
RGD:38676478
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
ALB
albumin
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
ALOX15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:19752233
RGD:5509626
NCBI chr17:4,686,339...4,696,877
Ensembl chr17:4,677,125...4,687,669
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20972769
NCBI chr11:111,673,539...111,675,428
Ensembl chr11:115,606,136...115,608,122
G
AQP5
aquaporin 5
ISO
associated with Disseminated Intravascular Coagulation;mRNA,protein:decreased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr12:38,789,505...38,793,305
Ensembl chr12:39,684,008...39,687,127
G
ASCL1
achaete-scute family bHLH transcription factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20554700
NCBI chr12:100,536,895...100,539,737
Ensembl chr12:103,932,302...103,932,999
G
BAX
BCL2 associated X, apoptosis regulator
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
BCL2
BCL2 apoptosis regulator
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
C3
complement C3
treatment
ISO
RGD
PMID:22763771
RGD:11040808
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CASP3
caspase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:29755641 PMID:32062619
RGD:13782288
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:29755641
RGD:13782288
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15612528
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CAV1
caveolin 1
treatment
ISO
RGD
PMID:24919947
RGD:10045573
NCBI chr 7:108,497,125...108,533,090
Ensembl chr 7:121,193,424...121,229,655
G
CCL2
C-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:21767135
RGD:6480432
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCR1
C-C motif chemokine receptor 1
ISO
associated with Pancreatitis
RGD
PMID:17312463
RGD:5688151
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
G
CD36
CD36 molecule (CD36 blood group)
ISO
associated with Malaria
RGD
PMID:18483551
RGD:6893505
NCBI chr 7:72,566,478...72,643,517
Ensembl chr 7:86,265,114...86,305,865
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
associated with Reperfusion Injury mRNA, protein:increased expression:lung
RGD
PMID:7814607 PMID:15557650
RGD:5135247 RGD:5135256
NCBI chr 4:50,357,643...50,359,822
Ensembl chr 4:56,189,961...56,192,402
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression
ISO
associated with sepsis;protein:increased expression:blood serum (human)
RGD
PMID:28506137
RGD:40925937
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
CXCR2
C-X-C motif chemokine receptor 2
treatment
ISO
associated with Pancreatitis
RGD
PMID:17014919
RGD:7257703
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:lung
RGD
PMID:16882535 PMID:18367723
RGD:5135235 RGD:5147744
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
CYSLTR1
cysteinyl leukotriene receptor 1
treatment
ISO
associated with Endotoxemia
RGD
PMID:27703200
RGD:40903067
NCBI chr X:67,412,410...67,469,366
Ensembl chr X:77,524,455...77,525,468
G
DDIT3
DNA damage inducible transcript 3
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr12:31,406,332...31,410,293
Ensembl chr12:31,664,743...31,668,701
G
EDN1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16625121
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
G
EGFR
epidermal growth factor receptor
ISO
RGD
PMID:20935109
RGD:5131862
NCBI chr 7:55,614,042...55,807,285
Ensembl chr 7:56,046,296...56,111,615
G
ELANE
elastase, neutrophil expressed
treatment
ISO
associated with Shock, Hemorrhagic; protein:increased expression:perfusate:
RGD
PMID:15257085 PMID:17203197 PMID:18283562
RGD:10450548 RGD:10450585 RGD:10450587
NCBI chr19:276,499...280,598
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26840748
NCBI chr 1:201,271,366...201,306,635
Ensembl chr 1:206,272,866...206,307,581
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:22051199
RGD:5688354
NCBI chr 8:26,761,090...26,818,436
Ensembl chr 8:23,964,094...24,017,749
G
ERN1
endoplasmic reticulum to nucleus signaling 1
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr17:58,132,889...58,224,012
Ensembl chr17:63,226,949...63,317,825
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:22804886
RGD:7387313
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression: respiratory system fluid/secretion
RGD
PMID:21964405
RGD:11341740
NCBI chr 1:97,190,381...97,203,076
Ensembl chr 1:95,918,502...95,931,050
G
FADD
Fas associated via death domain
treatment
ISO
associated with Shock, Hemorrhagic
RGD
PMID:24122010
RGD:11341811
NCBI chr11:65,300,889...65,305,020
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FCGR1A
Fc gamma receptor Ia
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:125,127,073...125,136,911
Ensembl chr 1:128,805,484...128,814,220
G
FCGR2B
Fc gamma receptor IIb
treatment
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:137,074,342...137,090,962
Ensembl chr 1:140,882,043...140,890,637
G
FGA
fibrinogen alpha chain
ISO
protein:increased expression:blood (rat)
RGD
PMID:22804886
RGD:7387313
NCBI chr 4:146,949,680...146,957,291
G
FLT1
fms related receptor tyrosine kinase 1
ISO
associated with Endotoxemia
RGD
PMID:21528367
RGD:5684427
NCBI chr13:9,584,850...9,779,542
G
FOXA1
forkhead box A1
ISO
mRNA,protein:increased expression:lung
RGD
PMID:19649697
RGD:151665511
NCBI chr14:18,347,284...18,352,705
G
GJA1
gap junction protein alpha 1
treatment
ISO
RGD
PMID:23576849
RGD:8662452
NCBI chr 6:119,213,513...119,227,617
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
protein:decreased expression:lung (rat)
RGD
PMID:25581610
RGD:13504847
NCBI chr10:96,012,345...96,046,266
Ensembl chr10:99,506,205...99,540,178
G
GSR
glutathione-disulfide reductase
ISO
RGD
PMID:7896613
RGD:7257562
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
GZMB
granzyme B
ISO
RGD
PMID:20018616
RGD:5135517
NCBI chr14:5,399,888...5,403,200
Ensembl chr14:23,523,619...23,526,931
G
HMGB1
high mobility group box 1
treatment
ISO
associated with Endotoxemia associated with Crush Injuries associated with Burns
RGD
PMID:19766246 PMID:23874764 PMID:30465396
RGD:10402098 RGD:34901874 RGD:4892587
NCBI chr13:11,737,942...11,894,923
Ensembl chr13:30,174,899...30,179,527
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16922808
RGD:5508470
NCBI chr 5:39,936,630...39,961,519
Ensembl chr 5:40,548,919...40,573,785
G
HMOX1
heme oxygenase 1
treatment
ISO
associated with Reperfusion Injury
RGD
PMID:20360627 PMID:20850789
RGD:4140418 RGD:4145326
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
HNRNPC
heterogeneous nuclear ribonucleoprotein C
ISO
protein:altered localization:lung (mouse)
RGD
PMID:19029002
RGD:10054390
NCBI chr14:2,022,280...2,083,215
G
HSPA5
heat shock protein family A (Hsp70) member 5
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr 9:96,351,645...96,356,761
Ensembl chr 9:124,865,211...124,870,458
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17973899 PMID:20569121 PMID:27525872
RGD:8547719
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IDO1
indoleamine 2,3-dioxygenase 1
treatment
ISO
RGD
PMID:25278421
RGD:39939031
NCBI chr 8:39,108,310...39,123,611
Ensembl chr 8:36,617,312...36,632,352
G
IFNG
interferon gamma
ISO
RGD
PMID:21767135
RGD:6480432
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
no_association treatment
ISO
associated with Reperfusion Injury;protein:increased expression:lung, plasma DNA:SNP:promoter:rs3021097 (human) DNA:SNP:promoter:-1082G>A (rs1800896) (human)
RGD
PMID:23801594 PMID:23902576 PMID:30412745
RGD:14975158 RGD:7364984 RGD:7365008
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL13
interleukin 13
ISO
mRNA:increased expression:lung
RGD
PMID:15461830
RGD:4145512
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28600744
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
treatment
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:24223666
RGD:8655952
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism protein:increased expression:lung mRNA, protein:increased expression:lung
RGD CTD
PMID:8613550 PMID:20153312 PMID:20663306 PMID:21767135 PMID:22982561 PMID:32062619 More...
RGD:4142531 RGD:4142807 RGD:4143193 RGD:6480432 RGD:7204498
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL1RL1
interleukin 1 receptor like 1
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21352201
RGD:5144222
G
IL1RN
interleukin 1 receptor antagonist
ISO
mRNA:increased expression:lung
RGD
PMID:8613550 PMID:15970097
RGD:4143168 RGD:4143193
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL2
interleukin 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:21767135
RGD:6480432
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:24681349
RGD:10402798
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL4I1
interleukin 4 induced 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36537648
NCBI chr19:46,902,656...46,942,213
Ensembl chr19:55,819,080...55,858,389
G
IL6
interleukin 6
ISO
protein:increased expression:bronchoalveolar lavage, blood, lung (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19995278 PMID:32062619
RGD:11062103
NCBI chr 7:23,415,922...23,420,767
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:21577093
RGD:36049795
NCBI chr12:22,661,613...22,721,203
Ensembl chr12:23,168,346...23,227,148
G
ITGAM
integrin subunit alpha M
treatment
ISO
associated with Hemorrhagic Shock
RGD
PMID:1347308 PMID:16096539
RGD:329901922 RGD:329901935
NCBI chr16:23,634,476...23,707,147
Ensembl chr16:31,630,146...31,702,406
G
ITGB2
integrin subunit beta 2
ISO
RGD
PMID:1374449
RGD:6482199
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
G
JAK3
Janus kinase 3
ISO
RGD
PMID:22359619
RGD:11531100
NCBI chr19:17,299,129...17,330,700
Ensembl chr19:18,283,560...18,300,964
G
KDR
kinase insert domain receptor
ISO
associated with Endotoxemia;mRNA, protein:decreased expression:lung
RGD
PMID:21528367
RGD:5684427
NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109
G
LOC100974886
uncharacterized LOC100974886
ISO
associated with Sepsis;mRNA:increased expression:lung mRNA, protein:increased expression:lung protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10069420 PMID:15557650 PMID:19106808 PMID:27525872
RGD:5135247 RGD:5135253 RGD:5147925
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
G
LOC100976904
growth-regulated alpha protein
ISO
associated with Sepsis;mRNA:increased expression:lung
RGD
PMID:10069420
RGD:5135253
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
G
LOC100986475
metallothionein-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr16:36,894,853...36,895,826
Ensembl chr16:56,007,922...56,028,093
G
LOC100991644
low affinity immunoglobulin gamma Fc region receptor II-a
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:136,892,311...136,906,450
G
LOC103783265
pulmonary surfactant-associated protein A1
ISO
mRNA, protein:increased expression:pneumocyte
RGD
PMID:8569184
RGD:4143451
NCBI chr10:76,571,312...76,575,820
G
MFN1
mitofusin 1
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 3:176,378,175...176,423,943
Ensembl chr 3:184,552,108...184,596,763
G
MFN2
mitofusin 2
ISO
mRNA, protein:increased expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 1:10,729,933...10,764,865
Ensembl chr 1:11,945,880...11,981,077
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MMP7
matrix metallopeptidase 7
ISO
associated with Sepsis
RGD
PMID:21567117
RGD:9685338
NCBI chr11:97,467,037...97,477,305
Ensembl chr11:100,960,032...100,971,099
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MPO
myeloperoxidase
ISO
associated with Kidney Reperfusion Injury; protein:increased activity:lung
RGD
PMID:22092133
RGD:6909173
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
G
MT1X
metallothionein 1X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr16:36,959,854...36,961,632
Ensembl chr16:56,092,218...56,093,976
G
MYLK
myosin light chain kinase
ISO
associated with Sepsis CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16399953 PMID:19374788
RGD:1581052
NCBI chr 3:120,711,705...120,983,432
Ensembl chr 3:127,614,173...127,793,261
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24812154
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NGF
nerve growth factor
ISO
RGD
PMID:17673270
RGD:5144065
NCBI chr 1:87,223,597...87,276,759
G
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33012731
NCBI chr 1:223,052,307...223,084,736
Ensembl chr 1:228,505,147...228,537,216
G
NOD2
nucleotide binding oligomerization domain containing 2
treatment
ISO
associated with Sepsis
RGD
PMID:22575870
RGD:8547530
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:16882535
RGD:5147744
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NPPA
natriuretic peptide A
ISO
RGD
PMID:23422200
RGD:7247713
NCBI chr 1:10,608,025...10,610,287
Ensembl chr 1:11,825,072...11,827,373
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:24669282 PMID:28065220
RGD:11035223 RGD:13442501
NCBI chr16:50,090,696...50,106,495
Ensembl chr16:69,470,288...69,489,731
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 3:190,890,242...190,995,133
Ensembl chr 3:201,207,607...201,312,358
G
P2RY12
purinergic receptor P2Y12
ISO
associated with Shock, Hemorrhagic
RGD
PMID:21841533
RGD:6480522
NCBI chr 3:148,364,151...148,412,231
G
PAK1
p21 (RAC1) activated kinase 1
ISO
DNA:hypermethylation
RGD
PMID:23546543
RGD:11533951
NCBI chr11:72,372,577...72,524,817
Ensembl chr11:76,015,998...76,104,197
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
associated with Pancreatitis, Experimental, Acute
RGD
PMID:16127429
RGD:11075069
NCBI chr 1:201,820,355...201,867,673
Ensembl chr 1:206,812,981...206,860,356
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:increased expression:lung,blood vessel:
RGD
PMID:17136598
RGD:9835397
NCBI chr12:77,114,282...77,224,116
Ensembl chr12:79,969,517...80,070,796
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr17:58,417,134...58,526,409
Ensembl chr17:63,511,784...63,579,067
G
PFKFB3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
ISO
associated with Endotoxemia;mRNA, protein:increased expression:lung (mouse)
RGD
PMID:31167111
RGD:41410778
NCBI chr10:6,185,415...6,294,641
Ensembl chr10:6,167,841...6,275,940
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
associated with endotoxemia
RGD
PMID:11714830 PMID:22198681
RGD:38599213 RGD:6482677
NCBI chr 7:98,841,974...98,885,446
Ensembl chr 7:111,570,148...111,611,614
G
PLA2G2A
phospholipase A2 group IIA
severity
ISO
RGD
PMID:19235614
RGD:6482722
NCBI chr 1:18,930,294...18,934,563
Ensembl chr 1:19,971,084...19,977,627
G
PLAU
plasminogen activator, urokinase
treatment
ISO
associated with Endotoxemia
RGD
PMID:21473829 PMID:23324284
RGD:5147760 RGD:7241552
NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:decreased expression:lung (rat) CTD Direct Evidence: therapeutic
RGD CTD
PMID:16083301 PMID:21153920
RGD:8553030
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
PRDM1
PR/SET domain 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33109608
NCBI chr 6:103,899,410...103,923,389
Ensembl chr 6:107,773,229...107,796,815
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
ISO
RGD
PMID:21595935
RGD:6484539
NCBI chr 5:69,581,748...69,620,721
Ensembl chr 5:74,627,830...74,666,505
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
associated with Pseudomonas Infections associated with Intestinal Reperfusion Injury
RGD
PMID:16553944 PMID:18367148
RGD:11100043 RGD:11250405
NCBI chr2B:32,846,899...32,859,060
Ensembl chr2B:128,083,794...128,094,625
G
PROCR
protein C receptor
treatment
ISO
RGD
PMID:20095324
RGD:13515130
NCBI chr20:31,500,838...31,543,928
Ensembl chr20:32,622,876...32,628,320
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:lung
RGD
PMID:19567182 PMID:20926798
RGD:5135287 RGD:5135496
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
SCGB1A1
secretoglobin family 1A member 1
ISO
protein:decreased expression:lung
RGD
PMID:16226776 PMID:18420837
RGD:5143982 RGD:5144142
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
G
SERPINC1
serpin family C member 1
treatment
ISO
associated with Endotoxemia
RGD
PMID:17940748
RGD:11035256
NCBI chr 1:149,421,737...149,435,301
Ensembl chr 1:153,126,031...153,139,369
G
SERPINE1
serpin family E member 1
treatment
ISO
associated with Sepsis associated with Shock, Hemorrhagic;mRNA:increased expression:lung (rat)
RGD
PMID:10745022 PMID:18182560 PMID:25934465
RGD:11075078 RGD:11080962 RGD:11080967
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
SERPING1
serpin family G member 1
treatment
ISO
RGD
PMID:11685347
RGD:8661650
NCBI chr11:52,838,502...52,855,781
Ensembl chr11:56,309,686...56,326,639
G
SFTPB
surfactant protein B
treatment
ISO
RGD
PMID:22295533
RGD:151667443
NCBI chr2A:85,708,485...85,718,120
Ensembl chr2A:87,257,244...87,268,332
G
SFTPD
surfactant protein D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30060251
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
G
SIRT2
sirtuin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32063085
NCBI chr19:35,984,453...36,005,582
Ensembl chr19:44,533,965...44,554,799
G
SLPI
secretory leukocyte peptidase inhibitor
treatment severity
ISO
associated with Endotoxemia
RGD
PMID:10092827 PMID:25466948
RGD:9999422 RGD:9999425
NCBI chr20:41,583,429...41,585,773
Ensembl chr20:42,673,417...42,675,773
G
TAC1
tachykinin precursor 1
ISO
RGD
PMID:19797759
RGD:5147812
NCBI chr 7:89,675,834...89,684,391
Ensembl chr 7:103,257,501...103,266,389
G
TACR1
tachykinin receptor 1
ISO
mRNA:increased expression:lung
RGD
PMID:18523300
RGD:5147819
NCBI chr2A:75,111,339...75,267,320
Ensembl chr2A:76,614,478...76,771,018
G
TFF1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr21:28,669,323...28,673,556
Ensembl chr21:41,988,039...41,992,270
G
TFF2
trefoil factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr21:28,653,077...28,657,709
Ensembl chr21:41,973,111...41,977,227
G
TGFB1
transforming growth factor beta 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16100012 PMID:25278421
RGD:39939031
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
THBD
thrombomodulin
treatment
ISO
associated with Endotoxemia
RGD
PMID:19342415 PMID:19536047 PMID:20095324
RGD:13515130 RGD:5131887 RGD:5685372
NCBI chr20:22,992,341...22,996,415
Ensembl chr20:23,345,917...23,347,812
G
TIMP2
TIMP metallopeptidase inhibitor 2
severity
ISO
RGD
PMID:10092827
RGD:9999422
NCBI chr17:72,928,692...73,001,892
Ensembl chr17:78,476,807...78,495,649
G
TLR4
toll like receptor 4
ISO
RGD
PMID:19567182
RGD:5135496
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
no_association treatment
ISO
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung DNA:SNP:promoter:rs1799964 (human) DNA:SNP:promoter:-308G>A (rs1800629) (human) associated with Liver Reperfusion Injury
RGD CTD
PMID:11129814 PMID:19106808 PMID:21767135 PMID:30412745 PMID:34390737
RGD:14975158 RGD:14995473 RGD:5147925 RGD:6480432
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFAIP6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26313688
NCBI chr2B:38,669,652...38,692,037
Ensembl chr2B:155,933,842...155,956,382
G
TREM1
triggering receptor expressed on myeloid cells 1
exacerbates ameliorates
ISO
RGD
PMID:26832696
RGD:127284840
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
G
TXN
thioredoxin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16298680
NCBI chr 9:81,399,056...81,411,607
Ensembl chr 9:109,565,557...109,578,311
G
USP18
ubiquitin specific peptidase 18
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33930521
G
VEGFA
vascular endothelial growth factor A
ISO
associated with Endotoxemia;mRNA, protein:altered expression:lung, plasma
RGD
PMID:21528367
RGD:5684427
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
VIP
vasoactive intestinal peptide
ISO
CTD Direct Evidence: therapeutic associated with Endotoxemia
CTD RGD
PMID:8643465 PMID:20441697
RGD:4145303
NCBI chr 6:150,564,545...150,573,582
Ensembl chr 6:155,254,652...155,263,730
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:9655743
RGD:13209002
NCBI chr2A:31,356,011...31,435,111
Ensembl chr2A:31,425,183...31,504,455
G
ZC3H12A
zinc finger CCCH-type containing 12A
severity
ISO
associated with toxic shock syndrome
RGD
PMID:23422584
RGD:39938961
NCBI chr 1:36,743,341...36,753,261
Ensembl chr 1:38,093,917...38,103,556
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all